Search Technologies
Displaying 1 - 1 of 1 results
Researchers at the University of Maryland have created hundreds of innovations that are available for licensing. Our Discovery Portfolio contains an exciting mix of vaccines, drug targets, therapeutics, devices and cutting edge techniques that promise to make a quantifiable impact on human health and the environment.
Search by keyword:
-
Repurposed drugs for Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Published Monday, November 24, 2014Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are viral respiratory diseases caused by novel coronavirus strains (SARS-CoV and MERS-CoV, respectively). Categorized as a select agent in 2012, approximately 9,000 cases of SARS have been reported, with 9.5% mortality rate. To date, there have been 1,917...
Investigator(s): Mathew Frieman, Lisa Hensley, Peter Jahrling
Categories: Therapeutics, Small molecules, Chemicals, Repurpose Drug
Keyword(s): MERS, SARS, Repurposed drugs, antiviral drugs
Docket: MF-2014-090